Evaluation of Oxidative Stress and Antioxidant Status during Normal Menstrual Cycle
Evaluation of Oxidative Stress and Antioxidant Status
Keywords:
Antioxidants, ascorbic acid, malondialdehyde (MDA), menstrual cycle, oxidative stressAbstract
Background & Objectives: Oxidative stress has been investigated to explain various physiological as well as pathological bases of many medical conditions. But very few data concerning the oxidative stress during normal menstrual cycle of eumenorrheic women are available. Thus, the purpose of study was to examine the physiological role of oxidative stress during normal menstrual cycle. Methods: 120 young healthy female subjects of reproductive age group (17-27 yrs), having regular menstrual cycle, were examined. Serum malondialdehyde (MDA), an oxidative stress biomarker and serum ascorbic acid (vitamin-C), an antioxidant vitamin were assessed in the follicular phase (on 7th day) and in the luteal phase (on 21st day) of normal menstrual cycle. Results: In the present study, significant higher (p<0.0001) levels of MDA and lower but non-significant (p>0.05) levels of ascorbic acid were observed in the luteal phase when compared to the follicular phase. Non-significant negative correlations were also observed between MDA and ascorbic acid in both the phases of normal menstrual cycle. Significant increase in serum MDA level coincided with the increased progesterone and estrogen levels during the luteal phase. High levels of estrogen may be the initiator of lipid peroxidation process which eventually ends up with cellular injury during the luteal phase. Interpretation & Conclusion: Oxidative stress has an important role to play in physiological phenomenon of the menstruation.
[Gupta K NJIRM 2015; 6(1):31-34]
References
2. Raharjo S, Sofos JN and Schmitt GR. Solid-phase acid extraction improves thiobarbituric acid methods to determine lipid oxidation. J Food Sci 1993; 58: 921-932.
3. Grunert RR and Phillips PH. A modification of nitroprusside method of analysis for glutathione. Arch Biochem 1951; 30(2): 217-225.
4. Sawada M and Carlson J. Superoxide radical production in plasma membrane samples from regressing corpora lutea. Can J Physiol Pharmacol 1989; 67(5): 465-471.
5. Harvey AJ, Kind KL and Thompson JG. REDOX regulation of early embryo development. Reproduction 2002; 123: 479-486.
6. Akande AA and Akinyinka AO. Serum malondialdehyde levels during menstrual cycle. Afr J Biotechnol 2005; 4(11): 1297-1299.
7. Agarwal A, Aponte-Mellado A, Premkumar BJ, Shaman A, Gupta S. The effects of oxidativestress on female reproduction: a review. Reprod Biol Endocrinol 2012; 10: 49.
8. Terada LS. Specificity in reactive oxidant signalling: Think globally, act locally. J Cell Biol 2006; 174: 615-623.
9. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta 1978; 90(1): 37-43.
10. Natelson S. Determination of ascorbic acid by using 2, 4 – dinitrophenyl hydrazine. Techniques of Clinical Chemistry. 3rd ed. Springfield, USA: Charles C. Thomas. 1971: pp. 165-166.
11. Karowicz-Bilinska A, Plodzidym M, Krol J, Lewinska A, Bartosz G. Changes of markers of oxidative stress during menstrual cycle. Redox Rep 2008; 13(5): 237-240.
12. Serviddio G, Loverro G, Vicino M, et al. Modulation of endometrial redox balance during the menstrual cycle: relation with sex hormones. J Clin Endocrinol Metab 2002; 87(6): 2843-2848.
13. Elhadd TA, Neary R, Abdu TA, et al. Influence of the hormonal changes during the normal menstrual cycle in healthy young women on soluble adhesion molecules, plasma homocysteine, free radical markers and lipoprotein fractions. Int Angiol 2003; 22(3): 222-228.
14. Browne RW, Bloom MS, Schisterman EF, et al. Analytical and biological variation of biomarkers of oxidative stress during the menstrual cycle. Biomarkers 2008; 11: 160-183.
15. Michos C, Kiortsis DN, Evangelou A, Karkabounas S. Antioxidant protection during the menstrual cycle : The effects of estradiol on ascorbic – dehydroascorbic acid plasma levels and total antioxidant plasma status in eumenorrheic women during the menstrual cycle. Acta Obstet Gynecol Scand 2006; 85(8): 960-965.
16. Mickelson O, Dippel AL and Todd RL. Plasma Vitamin C levels in women during the menstrual cycle. J Clin Endocrinol Metab 1943; 3(11): 600-602.
17. Hauck HM. Plasma levels and urinary excretion of ascorbic acid in women during the menstrual cycle. J Nutr 1947; 33(5): 511-514.
18. Ganong. Gonads: Development and function of the reproductive system. In: Review of Medical Physiology. William F. 13th ed. USA. Prentice-Hall Int. Inc. 1987; pp. 364-369.
19. Llewellyn-Jones D. Everywomen - A gynaecological guide for life. 4thed. The Chancer press. Great Britain: 1986: pp. 48.
20. Whitley RJ, Wayne M and Nelson BW. Endocrinology. In: Teitz Textbook of Clinical Chemistry. Carl Burtis and Edward Ashwood (editors). Philadephia: Saundera Company. 1992: pp. 1879.
21. Schisterman EF, Gaskins AJ, Mumford SL, et al. Influence of Endogenous Reproductive Hormones on F2-Isoprostane Levels in Premenopausal Women. Am J Epidemiol 2010; 172(4): 430-439.
22. Romero FJ, Bosch-Morell F, Romero MJ, Jareno EJ, Romero B, Roma MN. Lipid peroxidation products and antioxidants in human diseases. Environ Health Perspect 1998; 106: 1229-1234.
23. Sowers M, McConnell D, Jannausch ML, et al. Oestrogen metabolites in relation to isoprostanes as a measure of oxidative stress. Clin Endocrinol (Oxf) 2008; 68(5): 806-813.
24. Bednarek–Tupikowska G, Bohdanowicz–Pawlak A, Bidzinska B, Milewicz A, Antonowicz–Juchniewicz J, Andrzejak R. Serum lipid peroxide and superoxide dismutase activity in premenopausal and postmenopausal women. Gynecol Endocrinol 2001; 15(4): 298-303.
25. Lutoslawska G, Tkaczyk J, panczenco-kresowska B, Hubner-Wozniak E, Skierska E, Gajewski AK. Plasma TBARS, blood GSH concentrations, and erythrocyte antioxidant enzyme activities in regularly menstruating women with ovulatory and anovulatory menstrual cycles. Clin Chim Acta 2003; 331(1-2): 159-163.
